ERIN SPINKS: Open Payments
NPI 1225408297 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,380 in 78 payments from 17 companies in 2025. Trend: 2023 $1,479 · 2024 $1,295 · 2025 $1,380
Food & beverage: $1,364Education: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $375 |
| Ardelyx, Inc. | 8 | $153 |
| Ipsen Biopharmaceuticals, Inc | 4 | $110 |
| GENZYME CORPORATION | 4 | $104 |
| Medtronic, Inc. | 1 | $104 |
| Janssen Biotech, Inc. | 5 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| Enterra Medical, Inc. | 1 | $54 |
| PFIZER INC. | 2 | $37 |
Products named: RINVOQ, IBSRELA, DUPIXENT, IQIRVO, INTERSTIM, TREMFYA, LINZESS, XIFAXAN.
Industry payments across GA — which companies pay providers there.
